Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy.

Principe N, Kidman J, Goh S, Tilsed CM, Fisher SA, Fear VS, Forbes CA, Zemek RM, Chopra A, Watson M, Dick IM, Boon L, Holt RA, Lake RA, Nowak AK, Lesterhuis WJ, McDonnell AM, Chee J. Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy. Front Immunol. 2020; 11:584423.

View in: PubMed

subject areas

Animals
Antigens, Neoplasm
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Granzymes
Immunologic Memory
Lymphocyte Activation
Mice
Mice, Inbred BALB C
T-Lymphocytes, Cytotoxic
T-Lymphocytes, Regulatory

authors with profiles

Robert Holt

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support